Zobrazeno 1 - 10
of 12 241
pro vyhledávání: '"metabolic dysfunction–associated steatotic liver disease"'
Autor:
Jaehyun Bae1, Eugene Han2, Hye Won Lee3, Cheol-Young Park4, Choon Hee Chung5, Dae Ho Lee6, Eun-Hee Cho7, Eun-Jung Rhee4, Ji Hee Yu8, Ji Hyun Park9, Ji-Cheol Bae10, Jung Hwan Park11, Kyung Mook Choi8, Kyung-Soo Kim12, Mi Hae Seo13, Minyoung Lee14, Nan-Hee Kim8, So Hun Kim15, Won-Young Lee4, Woo Je Lee16
Publikováno v:
Diabetes & Metabolism Journal. Nov2024, Vol. 48 Issue 6, p1015-1028. 14p.
Autor:
Omaña-Guzmán, Isabel1 (AUTHOR), Rosas-Diaz, Marisol2 (AUTHOR), Martínez-López, Yoscelina Estrella3 (AUTHOR), Perez-Navarro, L. Monserrat4 (AUTHOR), Diaz-Badillo, Alvaro5 (AUTHOR), Alanis, Anthony6 (AUTHOR), Bustamante, Alejandra7 (AUTHOR), Castillo-Ruiz, Octelina8 (AUTHOR), del Toro-Cisneros, Noemi9 (AUTHOR), Esquivel-Hernandez, Diego Armando10 (AUTHOR), Garcia-Villalobos, Gloria4 (AUTHOR), Garibay-Nieto, Nayely1 (AUTHOR), Garcia-Oropesa, Esperanza Milagros2 (AUTHOR), Hernandez-Martinez, Juan Carlos2 (AUTHOR), Lopez-Sosa, Elena Beatriz11 (AUTHOR), Maldonado, Carlos12 (AUTHOR), Martinez, David13 (AUTHOR), Membreno, Joshua6 (AUTHOR), Moctezuma-Chavez, Oscar Omar14 (AUTHOR), Munguia-Cisneros, Claudia X.15 (AUTHOR)
Publikováno v:
BMC Medicine. 11/21/2024, Vol. 22 Issue 1, p1-27. 27p.
Autor:
ElGhandour, Ahmed Mohamed1 (AUTHOR), Teama, Nahla Mohamed2 (AUTHOR) nahlateama@med.asu.edu.eg, Kamal, Marwa Abdullah1 (AUTHOR), Nashaat, Ehab Hassan1 (AUTHOR), Ghani, Amani Mohamed Abdel1,3 (AUTHOR), Abdo, Ahmad Abbas1 (AUTHOR)
Publikováno v:
Egyptian Liver Journal. 11/5/2024, Vol. 14 Issue 1, p1-13. 13p.
Autor:
Yun Kyu Lee1, Dong Hyeon Lee1,2, Sae Kyung Joo2, Heejoon Jang2, Young Ho So3, Siwon Jang3, Dong Ho Lee4, Jeong Hwan Park5, Mee Soo Chang5, Won Kim1,2 drwon1@snu.ac.kr
Publikováno v:
Gut & Liver. Nov2024, Vol. 18 Issue 6, p1048-1059. 12p.
Autor:
Alexopoulos, Anastasia-Stefania1,2 (AUTHOR) asa61@duke.edu, Danus, Susanne1 (AUTHOR), Parish, Alice3 (AUTHOR), Olsen, Maren K.2,3 (AUTHOR), Batch, Bryan C.1 (AUTHOR), Thacker, Connie R.1 (AUTHOR), Moylan, Cynthia A.4 (AUTHOR), Crowley, Matthew J.1,2 (AUTHOR)
Publikováno v:
Diabetes Therapy. Nov2024, Vol. 15 Issue 11, p2417-2427. 11p.
Publikováno v:
Diabetes, Metabolic Syndrome and Obesity, Vol Volume 17, Pp 4735-4747 (2024)
Yan Han,1,2,* Jinhan Liu,2,3,* Wenjian Li,4 Fan Zhang,1,2 Yonghua Mao1,5 1Department of Endocrinology, Changzhou Third People’s Hospital, Changzhou Medical Center, Nanjing Medical University, Changzhou, Jiangsu, People’s Republic of China
Externí odkaz:
https://doaj.org/article/6025eee0f7af482abdc40dec3a0b9929
Publikováno v:
Clinical Diabetes and Endocrinology, Vol 10, Iss 1, Pp 1-19 (2024)
Abstract Background Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing health concern and the risk of its development is connected with the increasing prevalence of metabolic syndrome (MetS) which occurs as a result of some
Externí odkaz:
https://doaj.org/article/a7550d63464f41babd1ee57f94d7fdb1
Publikováno v:
Artificial Cells, Nanomedicine, and Biotechnology, Vol 52, Iss 1, Pp 355-369 (2024)
The global epidemic of metabolic diseases has led to the emergence of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH), which pose a significant threat to human health. Despi
Externí odkaz:
https://doaj.org/article/50453e0ef3234c80889052aa0ffa51a5
Publikováno v:
BMC Pediatrics, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Background Aspartate transaminase-to-platelet ratio index (APRI) is an easy and useful predictor of hepatic fibrosis in patients with chronic hepatic disease, and it significantly correlates with the degree of hepatic fibrosis in adult patie
Externí odkaz:
https://doaj.org/article/98c4f7dc6bfb484c87a217d7ea1a65c5
Autor:
Isabel Omaña-Guzmán, Marisol Rosas-Diaz, Yoscelina Estrella Martínez-López, L. Monserrat Perez-Navarro, Alvaro Diaz-Badillo, Anthony Alanis, Alejandra Bustamante, Octelina Castillo-Ruiz, Noemi del Toro-Cisneros, Diego Armando Esquivel-Hernandez, Gloria Garcia-Villalobos, Nayely Garibay-Nieto, Esperanza Milagros Garcia-Oropesa, Juan Carlos Hernandez-Martinez, Elena Beatriz Lopez-Sosa, Carlos Maldonado, David Martinez, Joshua Membreno, Oscar Omar Moctezuma-Chavez, Claudia X. Munguia-Cisneros, Edna J. Nava-González, Adriana L. Perales-Torres, Adolfo Pérez-García, Hector Rivera-Marrero, Alisha Valdez, Alfonso Alejandro Vázquez-Chávez, Carlos Ramirez-Pfeiffer, Kathleen V. Carter, Beatriz Tapia, Leonel Vela, Juan Carlos Lopez-Alvarenga
Publikováno v:
BMC Medicine, Vol 22, Iss 1, Pp 1-27 (2024)
Abstract Background Metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as non-alcoholic fatty liver disease (NAFLD), is a prevalent hepatic condition linked to metabolic alterations. It gradually causes liver damage an
Externí odkaz:
https://doaj.org/article/8f2e26f0098b4c84873c9840354f1ce4